{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:31:49Z","timestamp":1790487109214,"version":"4.1.0"},"reference-count":26,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.3892\/or.2017.5464","type":"journal-article","created":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T05:14:37Z","timestamp":1487308477000},"page":"2193-2200","source":"Crossref","is-referenced-by-count":25,"title":["miR-9 regulates the multidrug resistance of chronic myelogenous leukemia by targeting ABCB1"],"prefix":"10.3892","volume":"37","author":[{"given":"Yan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,2,17]]},"reference":[{"key":"key20180107224350_b1-or-37-04-2193","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/leu.2010.159","article-title":"Insights into the stem cells of chronic myeloid leukemia","volume":"24","author":"Sloma","year":"2010","journal-title":"Leukemia"},{"key":"key20180107224350_b2-or-37-04-2193","doi-asserted-by":"crossref","first-page":"S2075","DOI":"10.1002\/1097-0142(19901015)60:8+<2075::AID-CNCR2820601521>3.0.CO;2-F","article-title":"Multidrug resistance in ovarian cancer","volume":"60","author":"Fojo","year":"1987","journal-title":"Cancer"},{"key":"key20180107224350_b3-or-37-04-2193","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fonc.2014.00002","article-title":"Small and innovative molecules as new strategy to revert MDR","volume":"4","author":"Zinzi","year":"2014","journal-title":"Front Oncol"},{"key":"key20180107224350_b4-or-37-04-2193","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1002\/ijc.27912","article-title":"P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel","volume":"132","author":"Hendrikx","year":"2013","journal-title":"Int J Cancer"},{"key":"key20180107224350_b5-or-37-04-2193","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejphar.2012.09.046","article-title":"Reversal of P-gp and MRP1-mediated multidrug resistance by H6, a gypenoside aglycon from Gynostemma pentaphyllum, in vincristine-resistant human oral cancer (KB\/VCR) cells","volume":"696","author":"Zhu","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"key20180107224350_b6-or-37-04-2193","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.4081\/hr.2012.e18","article-title":"Overexpression of lung resistance-related protein and P-glycoprotein and response to induction chemotherapy in acute myelogenous leukemia","volume":"4","author":"Tsuji","year":"2012","journal-title":"Hematol Rep"},{"key":"key20180107224350_b7-or-37-04-2193","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ydbio.2006.08.028","article-title":"microRNAs as oncogenes and tumor suppressors","volume":"302","author":"Zhang","year":"2007","journal-title":"Dev Biol"},{"key":"key20180107224350_b8-or-37-04-2193","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1182\/blood-2014-06-581926","article-title":"MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors","volume":"125","author":"Wang","year":"2015","journal-title":"Blood"},{"key":"key20180107224350_b9-or-37-04-2193","doi-asserted-by":"crossref","first-page":"e61858","DOI":"10.1371\/journal.pone.0061858","article-title":"Inhibition of BCR\/ABL protein expression by miR-203 sensitizes for imatinib mesylate","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"key20180107224350_b10-or-37-04-2193","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.4161\/epi.6.10.16535","article-title":"Aberrant hypermethylation of miR-9 genes in gastric cancer","volume":"6","author":"Tsai","year":"2011","journal-title":"Epigenetics"},{"key":"key20180107224350_b11-or-37-04-2193","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1158\/1535-7163.MCT-12-0001","article-title":"microRNA-9 targets matrix metalloproteinase 14 to inhibit invasion, metastasis, and angiogenesis of neuroblastoma cells","volume":"11","author":"Zhang","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"key20180107224350_b12-or-37-04-2193","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1158\/0008-5472.CAN-05-1783","article-title":"MicroRNA gene expression deregulation in human breast cancer","volume":"65","author":"Iorio","year":"2005","journal-title":"Cancer Res"},{"key":"key20180107224350_b13-or-37-04-2193","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1158\/1078-0432.CCR-11-2450","article-title":"Genome-wide miRNA expression profiling identifies miR-9-3 and miR-193a as targets for DNA methylation in non-small cell lung cancers","volume":"18","author":"Heller","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key20180107224350_b14-or-37-04-2193","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1476-4598-12-173","article-title":"Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia - implications on constitutive activation of NF\u03baB pathway","volume":"12","author":"Wang","year":"2013","journal-title":"Mol Cancer"},{"key":"key20180107224350_b15-or-37-04-2193","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1002\/ijc.25260","article-title":"miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines","volume":"127","author":"Zhu","year":"2010","journal-title":"Int J Cancer"},{"key":"key20180107224350_b16-or-37-04-2193","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/onc.2010.487","article-title":"MicroRNA-221\/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways","volume":"30","author":"Rao","year":"2011","journal-title":"Oncogene"},{"key":"key20180107224350_b17-or-37-04-2193","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/0008-5472.CAN-07-2488","article-title":"MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN","volume":"68","author":"Yang","year":"2008","journal-title":"Cancer Res"},{"key":"key20180107224350_b18-or-37-04-2193","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/1479-5876-11-265","article-title":"MiR-370 sensitizes chronic myeloid leukemia K562 cells to homoharringtonine by targeting Forkhead box M1","volume":"11","author":"Zhou","year":"2013","journal-title":"J Transl Med"},{"key":"key20180107224350_b19-or-37-04-2193","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1158\/0008-5472.CAN-13-1748","article-title":"Inhibition of miR-17 and miR-20a by oridonin triggers apoptosis and reverses chemoresistance by derepressing BIM-S","volume":"74","author":"Weng","year":"2014","journal-title":"Cancer Res"},{"key":"key20180107224350_b20-or-37-04-2193","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/cas.12339","article-title":"Downregulation of miR-217 correlates with resistance of Ph+ leukemia cells to ABL tyrosine kinase inhibitors","volume":"105","author":"Nishioka","year":"2014","journal-title":"Cancer Sci"},{"key":"key20180107224350_b21-or-37-04-2193","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.leukres.2015.07.008","article-title":"Silencing of miR-21 sensitizes CML CD34+ stem\/progenitor cells to imatinib-induced apoptosis by blocking PI3K\/AKT pathway","volume":"39","author":"Wang","year":"2015","journal-title":"Leuk Res"},{"key":"key20180107224350_b22-or-37-04-2193","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/jnci\/djt302","article-title":"miR-9 regulation of BRCA1 and ovarian cancer sensitivity to cisplatin and PARP inhibition","volume":"105","author":"Sun","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"key20180107224350_b23-or-37-04-2193","doi-asserted-by":"crossref","first-page":"9631","DOI":"10.1007\/s13277-015-3713-7","article-title":"miR-9 promotes cell proliferation and inhibits apoptosis by targeting LASS2 in bladder cancer","volume":"36","author":"Wang","year":"2015","journal-title":"Tumour Biol"},{"key":"key20180107224350_b24-or-37-04-2193","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1158\/1535-7163.MCT-08-0021","article-title":"Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin","volume":"7","author":"Kovalchuk","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"key20180107224350_b25-or-37-04-2193","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.bcp.2008.06.007","article-title":"Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1\/P-glycoprotein expression in human cancer cells","volume":"76","author":"Zhu","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"key20180107224350_b26-or-37-04-2193","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1111\/j.1582-4934.2010.01213.x","article-title":"Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia","volume":"15","author":"Feng","year":"2011","journal-title":"J Cell Mol Med"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2017.5464\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T17:56:09Z","timestamp":1515347769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2017.5464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,17]]},"references-count":26,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,2,17]]},"published-print":{"date-parts":[[2017,3]]}},"alternative-id":["10.3892\/or.2017.5464"],"URL":"https:\/\/doi.org\/10.3892\/or.2017.5464","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,17]]}}}